Tavio Capital’s Celgene Corp CELG Stock Holding History

Tavio Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-182,027	Closed	-$16.3M	–	20
2018 Q3	$16.3M	Buy	182,027 +56,619	+45%	+$5M	6.35%	6
2018 Q2	$9.96M	Buy	+125,408	New	+$10.4M	3.37%	14

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tavio Capital's CELG Position: Q4 2018 in Review

Tavio Capital sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 182,027 shares — an estimated $16.3M sold.

Tavio Capital first reported a position in CELG in Q2 2018 and held it in 2 quarters. The position peaked at $16.3M in Q3 2018. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

Tavio Capital reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
Tavio Capital sold 182,027 Celgene Corp shares in Q4 2018, an estimated $16.3M.
Tavio Capital first reported a position in Celgene Corp in Q2 2018 and held it in 2 quarters.
Tavio Capital's Celgene Corp position peaked at $16.3M in Q3 2018.
1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Tavio Capital's 13F filing for Q4 2018, filed 14 Feb 2019.